5-氨基-1,2,4-噻二唑 | 7552-07-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 5-氨基-1,2,4-噻二唑
• 中文别名: 5-氨基-1,2,4三噻唑(BASE)
• 英文名称: 1,3,4-thiadiazol-5-amine
• 英文别名: 1,2,4-thiadiazol-5-amine；5-amino-1,2,4-thiadiazole；1,2,4-thiadiazole-5-amine；2-amino-1,3,5-thiadiazole
• CAS: 7552-07-0
• 化学式: C₂H₃N₃S
• mdl: MFCD01102171
• 分子量: 101.132
• InChiKey: VJHTZTZXOKVQRN-UHFFFAOYSA-N

物化性质

• 熔点：
  112-115°C
• 沸点：
  238.9±23.0 °C(Predicted)
• 密度：
  1.495±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  6
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  80
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 危险类别码：
  R20/21/22
• 海关编码：
  2934999090
• 安全说明：
  S22,S36/37
• 危险性防范说明：
  P280
• 危险性描述：
  H302,H312,H332
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1,2,4-Thiadiazol-5-amine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1,2,4-Thiadiazol-5-amine
CAS number: 7552-07-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C2H3N3S
Molecular weight: 101.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-氨基-1,2,4-噻二唑 在 盐酸 作用下， 以 甲醇 为溶剂， 反应 1.0h， 生成 5-氨基-1,2,4-噻二唑盐酸盐
  参考文献：
  名称：

  HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS

  摘要：

  本发明涉及用作离子通道抑制剂的杂环衍生物。该发明还提供了包含本发明化合物的药学上可接受的组合物，以及使用这些组合物治疗各种疾病的方法。

  公开号：

  US20090131440A1
• 作为产物：
  描述：

  2-amino-4-dimethylamino-1,3-thiazabuta-1,3-diene 在 hydroxylamine-O-sulfonic acid 、 三乙胺 作用下， 以 乙醇 为溶剂， 反应 27.0h， 以47%的产率得到5-氨基-1,2,4-噻二唑
  参考文献：
  名称：

  HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS

  摘要：

  本发明涉及用作离子通道抑制剂的杂环衍生物。该发明还提供了包含本发明化合物的药学上可接受的组合物，以及使用这些组合物治疗各种疾病的方法。

  公开号：

  US20090131440A1

文献信息

• [EN] FTO INHIBITORS<br/>[FR] INHIBITEURS DE FTO
  申请人：NAT INST OF BIOLOGICAL SCIENCES BEIJING

  公开号：WO2016206573A1

  公开（公告）日：2016-12-29

  The invention provides compounds that inhibit FTO (fat mass and obesity), including pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof, particularly obesity, with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.

  这项发明提供了抑制FTO（脂肪质量和肥胖）的化合物，包括药用可接受的盐、氢化物和立体异构体。这些化合物用于制备药物组合物，以及制备和使用的方法，包括使用有效量的化合物或组合物治疗有需要的人，特别是肥胖症，并检测人的健康或状况的改善。
• Chemical Compounds
  申请人：Brown Alan Daniel

  公开号：US20120010182A1

  公开（公告）日：2012-01-12

  The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to new sulfonamide Nav1.7 inhibitors of formula (I): or pharmaceutically acceptable salts thereof, wherein Z 1 , R a , R b , R 1 , R 2 , R 3 , R 4 and R 5 are as defined in the description. Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.

  该发明涉及磺胺衍生物，其在医学上的应用，含有它们的组合物，其制备方法以及用于这些方法的中间体。 更具体地，该发明涉及公式（I）的新磺胺基Nav1.7抑制剂： 或其药学上可接受的盐，其中Z 1 ，R a ，R b ，R 1 ，R 2 ，R 3 ，R 4 和R 5 如描述中所定义。 Nav 1.7抑制剂在治疗各种疾病，特别是疼痛方面具有潜在用途。
• [EN] HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES ET LEUR UTILISATION DANS LA PRÉVENTION OU LE TRAITEMENT D'INFECTIONS BACTÉRIENNES
  申请人：MUTABILIS

  公开号：WO2018060481A1

  公开（公告）日：2018-04-05

  The invention relates to a compound of formula (I) and a racemate, an enantiomer, a diastereoisomer, a geometric isomer or a pharmaceutically acceptable salt thereof, and its use as antibacterial agent.

  这项发明涉及一种式(I)的化合物及其外消旋体、对映体、二对映异构体、几何异构体或药学上可接受的盐，并且其作为抗菌剂的用途。
• Quinolone derivative or salt thereof and antibacterial containing the
  申请人：Wakunaga Seiyaku Kabushiki Kaisha

  公开号：US05412098A1

  公开（公告）日：1995-05-02

  A quinolone derivative represented by the below-described formula (1), or a salt thereof: ##STR1## wherein R.sup.1 represents a hydrogen atom, or a carboxyl protective group, R.sup.2 represents a hydrogen atom, halogen atom or a lower alkyl group, X represents a hydrogen atom or a halogen atom, Y represents a halogen atom, a cyclic amino group which may have a substituent, a cyclo- lower alkenyl group which may have a substituent, or a group R.sup.3 --(CH.sub.2).sub.m --A-- (wherein R.sup.3 represents a hydrogen atom or an amino group which may have a substituent, A represents an oxygen atom or a sulfur atom and m represents a number of 0 to 3), Z represents a nitrogen atom or a group C--R.sup.4 (wherein R.sup.4 represents a hydrogen atom or a halogen atom), W represents a five-membered heterocyclic group which may have a substituent and which has 3 or more hetero-atoms, among which at least 2 hetero-atoms are nitrogen atoms, and n represents a number of 0 to 2; and an antibacterial agent containing the compounds. Since the above-mentioned compounds exhibit excellent antibacterial activities and are highly safe, they are useful as pharmaceuticals for the human and animals, medicines for fishes, pesticides, preservatives for foods, and the like.

  以下式(1)表示的喹诺酮衍生物，或其盐：STR1## 其中，R.sup.1表示氢原子或羧酸保护基团，R.sup.2表示氢原子、卤素原子或低级烷基，X表示氢原子或卤素原子，Y表示卤素原子、可能带有取代基的环状氨基、可能带有取代基的环状低级烯基或R.sup.3--(CH.sub.2).sub.m --A-- (其中R.sup.3表示氢原子或可能带有取代基的氨基，A表示氧原子或硫原子，m表示0到3的数字)，Z表示氮原子或C--R.sup.4基团(其中R.sup.4表示氢原子或卤素原子)，W表示可能带有取代基的五元杂环基团，该基团含有3个或更多个杂原子，其中至少2个是氮原子，n表示0到2的数字；以及含有这些化合物的抗菌剂。由于上述化合物具有卓越的抗菌活性和高度安全性，因此它们作为人畜用医药、鱼药、农药、食品防腐剂等方面非常有用。
• [EN] BIARYL ETHER SULFONAMIDES AND THEIR USE AS THERAPEUTIC AGENTS<br/>[FR] BIARYLÉTHERSULFONAMIDES ET LEUR UTILISATION EN TANT QU'AGENTS THÉRAPEUTIQUES
  申请人：XENON PHARMACEUTICALS INC

  公开号：WO2013064984A1

  公开（公告）日：2013-05-10

  This invention is directed to biaryl ether sulfonamides, or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.

  这项发明涉及联苯醚磺酰胺，或其药用可接受的盐、溶剂合物或前药，用于治疗和/或预防钠通道介导的疾病或症状，如疼痛。

表征谱图